Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging. - Wikidata - wikimedia - TriplyDB

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

http://www.wikidata.org/entity/Q34164704

about

Intrabody and Parkinson's disease Multimodality and nanoparticles in medical imaging Antibody-based imaging of HER-2: moving into the clinic.Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning.Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling PET/CT and breast cancer.Evaluation of two internalizing carcinoembryonic antigen reporter genes for molecular imaging Inorganic nanoparticle-based contrast agents for molecular imaging Translational molecular imaging for cancer.An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors.Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.Recent trends in antibody-based oncologic imaging A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT.Affinity peptide for targeted detection of dysplasia in Barrett's esophagus.Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging.Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology Tailoring antibodies for radionuclide delivery.Self-assembly of antibodies by chemical induction [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.Tumor-associated antigens and biomarkers in cancer and immune therapy.The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.The absence of a clathrin adapter confers unique polarity essential to proximal tubule function In vivo Noninvasive Small Animal Molecular Imaging Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2 A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules.Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.Antibody vectors for imaging.Immuno-positron emission tomography in cancer models.Pretargeted molecular imaging and radioimmunotherapy.

P2860

Q24653530-4505DEB9-2603-45CD-9970-4934A0CC8AD9 Q30407070-53635D17-1FD2-43B4-A25A-BEA96DFC642A Q30423880-6FEBD559-4763-454C-92EE-E746FAC0EB84 Q30480648-D5D9D10E-EEAC-4208-8F5D-1C2514608445 Q30497599-5F6C2FC9-5EE4-4563-9A9C-09C0A5453B36 Q33353929-D00717C0-FC53-4CAE-961D-B4FF61812B3E Q33781006-F8B2137B-F257-40AA-B6DA-7BBFCDCD4A63 Q34148890-D01921C4-C366-4B2C-9BB6-BA0F0C98AE1C Q34256370-08E8FD1C-1634-4581-B750-E87DCE6291A0 Q34354220-EB4B70B7-8F62-4F00-A9DF-6C4264B1AFA2 Q34644628-9DF205C2-A300-44C7-94BC-E1BF46A1F268 Q35173093-DFB5C6D4-38C8-4346-A411-6DC52DC900FA Q35583305-AE95A114-DA3B-4B49-86AC-01B229894346 Q35636908-FDF75E3F-1A50-4544-BCE7-1AAFF8F7B0D1 Q35643425-ADA215D3-8F0F-481C-B583-5DCFFAEC5ED3 Q35650526-AB258585-59EF-4A1F-806D-8D60CD7AB4DF Q35870232-3BC90DA3-4A06-4603-8C24-1BCC362E99F6 Q36080399-CC6442B5-F452-4418-8C82-A0371409EC36 Q36100348-4ACB5262-AAFE-45E6-A227-C1133946F957 Q36339722-ACEF68FB-EA77-401A-8BB2-B3939A89E7FB Q36349687-D05E3AB0-5110-4720-BB8E-629CB84FE0FC Q36611798-8A1F1656-A4C9-4D97-88A6-0AF6B19190CC Q36627997-A6D5563F-D2F3-4458-B939-048DE04617C7 Q36844959-F19E9EB3-D803-47DC-862D-64994E58A52E Q36903804-5871A623-6E24-4EC5-BB49-2BB22431A84C Q36934328-B8D8F125-6D4C-4859-8829-62FB2C63CF1D Q37083100-A6D2024F-E21A-415F-9D37-11CE1C1527D0 Q37158166-4A7FE1FD-70A5-4867-ABCB-3849C28A6726 Q37172093-F3D6B7A9-564F-4C13-B77D-23BCC7E2F39A Q37273125-B1CD98FB-5EC1-48A3-9664-0AB0539C49E7 Q37289040-00421713-A6C2-459D-842C-15F79E519709 Q37289392-C334C184-C3E1-4180-A4CB-29B87EFA7E0E Q37289402-F67B7A3E-F2A0-4C4F-A129-E7B6A1C0BDCF Q37330712-5BBC9676-6E16-4C9E-899B-55E0E92760F0 Q37394278-025693CE-30C6-40B4-B50C-9BEA8DE9640A Q37453801-110AF7C1-6646-4FB9-A8EA-C0ECFBC55E8A Q37519517-8F663E0E-BDFA-48C9-AAF8-29858F570042 Q37720850-5BDD50AF-F7DD-4AFE-8BD1-4EEE4BE33ED9 Q37720853-7A18A504-FB5C-4B26-8ACA-E9FFD7799822 Q38022016-F2EAA17D-C332-4EB0-B326-C31A7A8E2BA9

P2860

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

http://www.wikidata.org/entity/Q34164704

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@ast

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@en

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@nl

type

label

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@ast

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@en

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@nl

prefLabel

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@ast

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@en

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@nl

P1433

Q34164704-F8763762-8FAC-4A96-8B37-CF5DA286FB28

P1476

Q34164704-5409AE4E-C276-4CB9-B2CD-D35498DB69BA

P2093

Q34164704-10DC9461-54C1-472C-9F96-B34B6A729327

Q34164704-13861FE3-6A88-46EC-B298-D9014199BA72

Q34164704-18DFADB0-1F9E-468C-B363-BB7BA6F2EB0B

Q34164704-3D4B0E25-014C-4756-89E8-1E5D50442CBC

Q34164704-47782B47-E263-4574-85A7-C0F74C8EC86A

Q34164704-558C3573-C989-409C-98AA-4FD88B70DE77

Q34164704-62DDAD96-32D1-4838-8FAB-36CF858CB1C1

Q34164704-71BFC48F-474F-46EE-8726-A2ACFF0DA5DF

Q34164704-841CA40E-205E-41A8-8161-CA983406AA4B

Q34164704-CFD5916D-9426-4E3C-9A7F-436F7DC1E632

P2860

Q34164704-016ECEF9-C1CB-47C1-8702-AFA3A34B8123

Q34164704-0A0F8BE6-3883-49DE-B56B-593BAE09778A

Q34164704-0CAB355C-5B33-4D48-BC14-AF9ECB772E1D

Q34164704-0D78D9D3-EA48-418E-88FE-C3B3F553A10F

Q34164704-14C934EE-6F23-4B5A-99C3-AA7AF20E3EE9

Q34164704-1EE10678-A97C-485B-9CDA-8436D5258514

Q34164704-25E59A5A-F19D-4086-9F02-F9C0FA8CB08A

Q34164704-26F879AE-1C9C-4C89-AD5F-D384F3096FEB

Q34164704-2B871EC4-63AA-40F0-9AC1-8FB644F5EE6F

Q34164704-2F0BC207-627C-46A0-A93F-2BB6CC0FBCA3

P304

Q34164704-0DCD2D14-2031-4955-BB9C-A224E81EC5B4

P31

Q34164704-A19AAC81-8F5F-460A-B7E8-74A9A3240396

P356

Q34164704-C373223E-2058-47BB-8850-AA43938021D2

P407

Q34164704-9F31C992-D88C-4F00-A12D-F1D05FE0BD83

P433

Q34164704-206B0E21-3980-45EB-A2B2-09754C5E672E

P478

Q34164704-F7DCAEE9-0DA6-4939-B656-F9FF15263AAC

P577

Q34164704-B0BBA846-B022-4F80-AAAD-5DF0C780C979

P5875

Q34164704-A5ECF9F0-92C1-484C-8C51-ABCBF7828004

P698

Q34164704-3B8BA820-4C2D-4BA3-871F-AFF8CECEE4AA

P921

Q34164704-88622DD0-60F7-4C63-9DDB-2AD5825D727D

P932

Q34164704-441232B7-0C53-445D-8617-E47CEBC2EE4C

P356

0008-5472.CAN-04-4472

P1433

Cancer Research

P1476

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

@en

P2093

Andrew A Raubitschek

http://www.w3.org/2001/XMLSchema#string

Anna M Wu

http://www.w3.org/2001/XMLSchema#string

Anne-Line Anderson

http://www.w3.org/2001/XMLSchema#string

Desiree Crow

http://www.w3.org/2001/XMLSchema#string

Gobalakrishnan Sundaresan

http://www.w3.org/2001/XMLSchema#string

Jeffrey Y C Wong

http://www.w3.org/2001/XMLSchema#string

John E Shively

http://www.w3.org/2001/XMLSchema#string

Lawrence E Williams

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Michael F Press

http://www.w3.org/2001/XMLSchema#string

P2860

Humanization of an anti-p185HER2 antibody for human cancer therapy

"Diabodies": small bivalent and bispecific antibody fragments

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Humanization of the anti-CEA T84.66 antibody based on crystal structure data.

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

Designer genes: recombinant antibody fragments for biological imaging.

Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.

124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice

Preparation of monoclonal antibodies: strategies and procedures.

Exact and approximate rebinning algorithms for 3-D PET data.

P304

5907-5916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-4472

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7749185

http://www.w3.org/2001/XMLSchema#string

P698

15994969

http://www.w3.org/2001/XMLSchema#string

P921

P932

4161125

http://www.w3.org/2001/XMLSchema#string